Suppr超能文献

天然产物衍生的甾体类化合物作为潜在的抗利什曼原虫药物;疾病流行情况、潜在机制和未来展望。

Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives.

机构信息

Public Health Department, Health Sciences College at Lieth, Umm Al Qura University, Makkah, Saudi Arabia; University of Khartoum, Faculty of Public and Environmental Health, Sudan.

Department of Pharmacy, Facutly of Biological Sciences, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan.

出版信息

Steroids. 2023 May;193:109196. doi: 10.1016/j.steroids.2023.109196. Epub 2023 Feb 9.

Abstract

Leishmaniasis is a vector-borne infection caused by protozoan parasites from the genus leishmania and is among the most neglected tropical diseases. It is highly prevalent disease, affecting about 350 million population worldwide. Only limited number of anti-leishmanial agents are approved for clinical use till now and they are associated with side effects and have limited efficacy. Subsequently, natural products based discovery of more safe and effective drugs against leishmania is under scientific consideration. Various studies reported the efficacy of natural products against intracellular and extracellular forms of leishmania species. This work is aimed to evaluate current literature focused on the anti-leihmanial efficacy of steroidal moieties from natural products and their mechanism of action. Compounds including steroidal saponins, steroidal alkaloids and phytosterols were found to exhibit considerable anti-leishmanial efficacy. For instance, steroidal saponin, (25R)-spirost-5-en-3b-ol,3-O-α-rhamnopyranosyl-(1 → 4)-α-rhamnopyranosyl-(1 → 4)-[a-rhamnopyranosyl-(1 → 2)]-glucopyranoside isolated from A. paradoxum has completely eradicated Leishmania major promastigotes at 50 µg mL dose. Spirostanic saponins isolated from Solanum paniculatum L. were effective against Leishmania amazonensis promastigotes. Turgidosterones isolated from Panicum turgidum exhibited high leishmanicidal potentials against Leishmania donovani promastigotes with IC of 4.95-8.03 µg mL and even better activity against amastigotes exhibiting an IC of 4.50-9.29 µg mL. Likewise, racemoside-A from Asparagus racemosus was found effective against an antimonial sensitive (AG83) and antimonial resistant (GE1F8R) strains of the L. donovani. Moreover, steroidal alkaloids including hookerianamide-1, hookerianamide-H, hookerianamide-J, hookerianamide-K, dehydrosarsalignone, vagenine-A, sarcovagine-C, holaphylline, saracodine, holamine, 15-α hydroxyholamine, holacurtin, N-desmethyl holacurtine and elasticine has exhibited time and dose-dependent efficacy against various strains of leishmania. β-sitosterol was found active against multiple strains of leishmania. These compounds mainly exhibit their therapeutic efficacy via liberation of ROS, mitochondrial depolarization, morphological and ultra-structural changes, accumulation of lipid droplets, depletion of non-protein thiols and triggering apoptotic pathways. In conclusion, leishmaniasis is a major health problem in many countries. Plants-derived steroids moieties have reveled efficacy against leishmaniasis and is a source of lead compounds. Further detailed molecular studies are warranted for the discovery of more effective and safe anti-leishmanial drugs.

摘要

利什曼病是一种由原生动物寄生虫引起的虫媒传染病,属于最被忽视的热带病之一。它是一种高度流行的疾病,影响着全球约 3.5 亿人口。到目前为止,只有有限数量的抗利什曼病药物被批准用于临床使用,它们与副作用有关,疗效有限。因此,基于天然产物的发现更安全有效的抗利什曼病药物的研究正在引起科学界的关注。各种研究报告了天然产物对利什曼原虫的细胞内和细胞外形式的疗效。这项工作旨在评估目前关于天然产物中甾体部分的抗利什曼疗效及其作用机制的文献。已发现包括甾体皂苷、甾体生物碱和植物甾醇在内的化合物具有相当大的抗利什曼疗效。例如,从 A. paradoxum 中分离得到的甾体皂苷 (25R)-螺甾-5-烯-3b-醇、3-O-α-鼠李吡喃糖基-(1→4)-α-鼠李吡喃糖基-(1→4)-[α-鼠李吡喃糖基-(1→2)]-吡喃葡萄糖苷已完全根除 50μg·mL剂量的大孢子虫。从 Solanum paniculatum L. 中分离得到的螺旋甾烷皂苷对利什曼原虫前鞭毛体有效。从 Panicum turgidum 中分离得到的肿柄醇表现出对利什曼原虫前鞭毛体的高杀利什曼原虫活性,IC为 4.95-8.03μg·mL,对前鞭毛体的活性甚至更好,IC 为 4.50-9.29μg·mL。同样,来自 Asparagus racemosus 的 racemoside-A 被发现对锑敏感(AG83)和锑耐药(GE1F8R)的 L. donovani 菌株有效。此外,甾体生物碱包括钩藤酰胺-1、钩藤酰胺-H、钩藤酰胺-J、钩藤酰胺-K、脱水沙雷宁、vagenine-A、sarcovagine-C、holaphylline、saracodine、holamine、15-α羟基霍拉明、holacurtin、N-去甲基霍拉明和弹性素对各种利什曼原虫菌株表现出时间和剂量依赖性疗效。β-谷甾醇对多种利什曼原虫菌株均有活性。这些化合物主要通过释放 ROS、线粒体去极化、形态和超微结构变化、脂滴积累、非蛋白巯基耗竭和触发凋亡途径来发挥治疗效果。总之,利什曼病是许多国家的一个主要健康问题。植物来源的甾体类化合物已显示出对利什曼病的疗效,是潜在的先导化合物来源。为了发现更有效和安全的抗利什曼病药物,还需要进行更详细的分子研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验